V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 200005378 | 200005378 | null | null | Palliative (P) | 2013-11-17 | 2013-11-30 | IPILIMUMAB + NIVOLUMAB | N | null | LIPOSOMAL DOXORUBICIN | 100199485 |
| 200005382 | 200005382 | 1.78 | null | Palliative (P) | 2013-09-02 | 2015-07-21 | null | 2 | null | BINIMETINIB + ENCORAFENIB | 100725671 |
| 200005387 | 200005387 | null | null | null | null | 2018-10-13 | null | null | null | PEMBROLIZUMAB | 101583228 |
| 200005388 | 200005388 | null | null | Palliative (P) | 2016-07-21 | 2016-07-27 | PEMBROLIZUMAB | 02 | null | PEMBROLIZUMAB | 101032398 |
| 200005394 | 200005394 | 1.8 | 95 | null | null | 2018-10-15 | DABRAFENIB + TRAMETINIB | null | null | NIVOLUMAB | 100395212 |
| 200005410 | 200005410 | 1.84 | 102.6 | Curative (C) | 2016-06-29 | 2016-07-21 | IPILIMUMAB + NIVOLUMAB | 02 | N | OXALIPLATIN + MDG | 100572707 |
| 200005415 | 200005415 | null | null | Palliative (P) | 2020-02-01 | 2020-02-07 | DABRAFENIB + TRAMETINIB | 02 | N | IPILIMUMAB + NIVOLUMAB | 101738473 |
| 200005419 | 200005419 | null | null | Palliative (P) | 2018-09-15 | 2018-09-15 | NIVOLUMAB | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101855273 |
| 200005423 | 200005423 | 1.69 | 51 | null | null | 2018-04-03 | DABRAFENIB + TRAMETINIB | null | null | PEMBROLIZUMAB | 100470840 |
| 200005424 | 200005424 | null | null | Adjuvant (A) | 2012-03-20 | 2012-03-31 | Encorafenib | 02 | null | DABRAFENIB + TRAMETINIB | 101261652 |
| 200005426 | 200005426 | null | null | Adjuvant (A) | null | 2016-09-08 | NIVOLUMAB | 02 | null | PEMBROLIZUMAB | 100537226 |
| 200005447 | 200005447 | null | null | Palliative (P) | 2018-05-22 | 2018-05-25 | null | 02 | null | CHLORAMBUCIL + OBINUTUZUMAB | 101302057 |
| 200005457 | 200005457 | null | null | null | null | 2019-09-30 | null | null | null | TRIAL | 100036381 |
| 200005458 | 200005458 | null | null | Palliative (P) | null | 2016-09-27 | PEMBROLIZUMAB | N | null | BINIMETINIB + ENCORAFENIB | 100519404 |
| 200005459 | 200005459 | null | null | null | null | 2019-05-01 | DABRAFENIB + TRAMETINIB | null | null | IPILIMUMAB + NIVOLUMAB | 100144592 |
| 200005463 | 200005463 | null | null | null | null | 2013-04-22 | PEMBROLIZUMAB | null | null | PEMBROLIZUMAB | 101462070 |
| 200005466 | 200005466 | null | null | null | null | 2018-12-23 | IPILIMUMAB + NIVOLUMAB | null | null | IPILIMUMAB + NIVOLUMAB | 101598853 |
| 200005483 | 200005483 | null | null | null | null | 2019-01-17 | NIVOLUMAB | null | null | CAPECITABINE + OXALIPLATIN | 100565494 |
| 200005485 | 200005485 | null | null | Palliative (P) | 2019-06-28 | 2019-06-28 | DABRAFENIB + TRAMETINIB | 02 | null | IPILIMUMAB + NIVOLUMAB | 100849708 |
| 200005488 | 200005488 | null | null | null | null | 2019-08-19 | null | null | null | NIVOLUMAB | 100972628 |
| 200005499 | 200005499 | 1.68 | 91.4 | null | 2020-08-16 | 2020-08-16 | CAPECITABINE + CISPLATIN + Trastuzumab | 02 | null | IPILIMUMAB | 101611840 |
| 200005506 | 200005506 | null | null | Palliative (P) | 2018-10-04 | 2018-10-04 | PEMBROLIZUMAB | 02 | null | PEMBROLIZUMAB | 101007626 |
| 200005507 | 200005507 | null | null | 03 | 2016-09-11 | 2016-09-11 | DABRAFENIB + TRAMETINIB | 02 | null | NIVOLUMAB | 100263854 |
| 200005523 | 200005523 | null | null | Adjuvant (A) | 2017-02-03 | 2017-02-03 | PEMBROLIZUMAB | 2 | null | PEMBROLIZUMAB | 100026121 |
| 200005546 | 200005546 | null | null | null | 2019-12-29 | 2019-12-29 | null | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101640379 |
| 200005558 | 200005558 | null | null | Palliative (P) | 2016-06-01 | 2016-06-02 | null | 02 | null | IRINOTECAN + TEMOZOLOMIDE | 101855757 |
| 200005564 | 200005564 | null | null | Palliative (P) | null | 2019-10-09 | DABRAFENIB + TRAMETINIB | 01 | N | PEMBROLIZUMAB | 100401763 |
| 200005577 | 200005577 | null | null | null | null | 2019-07-31 | FEC | null | null | NIVOLUMAB | 101773960 |
| 200005587 | 200005587 | null | null | Palliative (P) | null | 2018-08-14 | PEMBROLIZUMAB | 02 | null | PEMBROLIZUMAB | 100437015 |
| 200005596 | 200005596 | null | null | Palliative (P) | 2016-07-06 | 2016-07-20 | IPILIMUMAB + NIVOLUMAB | 02 | N | CHLORAMBUCIL + RITUXIMAB | 100797400 |
| 200005638 | 200005638 | null | null | null | null | 2017-10-20 | IDELALISIB + RITUXIMAB | null | null | DABRAFENIB + TRAMETINIB | 101735724 |
| 200005645 | 200005645 | null | null | Palliative (P) | 2020-07-06 | 2020-07-19 | null | 02 | N | NIVOLUMAB | 100160252 |
| 200005660 | 200005660 | null | null | Neo-adjuvant (N) | 2019-08-29 | 2019-09-10 | PEMBROLIZUMAB | 02 | null | PEMBROLIZUMAB | 101725341 |
| 200005661 | 200005661 | null | null | Curative (C) | 2019-10-28 | 2019-10-30 | Enzalutamide | 02 | N | DABRAFENIB + TRAMETINIB | 100150345 |
| 200005664 | 200005664 | null | null | Curative (C) | 2021-05-08 | 2021-05-28 | null | 02 | N | NIVOLUMAB | 100351789 |
| 200005678 | 200005678 | null | null | null | null | 2019-10-17 | null | null | null | IPILIMUMAB | 101315961 |
| 200005680 | 200005680 | 1.62 | 92 | 03 | 2017-07-15 | 2017-07-19 | Binimetinib + Encorafenib | 02 | N | NIVOLUMAB | 100559729 |
| 200005706 | 200005706 | null | null | Palliative (P) | 2019-04-20 | 2019-05-04 | null | 02 | null | TRIAL UNSPECIFIED | 100817923 |
| 200005708 | 200005708 | null | null | null | null | 2018-05-28 | DABRAFENIB | null | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100509786 |
| 200005710 | 200005710 | null | null | null | null | 2021-11-24 | NIVOLUMAB | null | null | PAZOPANIB | 101562020 |
| 200005732 | 200005732 | null | null | null | null | 2016-06-28 | null | null | null | DABRAFENIB + TRAMETINIB | 100207125 |
| 200005733 | 200005733 | null | null | Palliative (P) | 2013-04-09 | 2013-04-20 | IDELALISIB + RITUXIMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 101700846 |
| 200005751 | 200005751 | 1.6 | 70 | null | null | 2020-01-21 | PEMBROLIZUMAB | null | null | PEMBROLIZUMAB | 100105086 |
| 200005777 | 200005777 | null | null | Palliative (P) | 2018-12-07 | 2018-12-07 | null | 02 | null | PEMBROLIZUMAB | 101769946 |
| 200005781 | 200005781 | null | null | null | null | 2018-03-04 | NIVOLUMAB | null | null | PEMBROLIZUMAB | 101474173 |
| 200005783 | 200005783 | null | null | Adjuvant (A) | 2018-04-26 | 2018-04-26 | PEMBROLIZUMAB | 02 | null | PEMBROLIZUMAB | 100999081 |
| 200005785 | 200005785 | null | null | null | null | 2015-02-22 | DABRAFENIB + TRAMETINIB | null | null | DABRAFENIB + TRAMETINIB | 101288525 |
| 200005799 | 200005799 | null | null | 03 | 2016-09-15 | 2016-10-01 | IPILIMUMAB + NIVOLUMAB | 02 | N | PEMBROLIZUMAB | 101464278 |
| 200005807 | 200005807 | null | null | Palliative (P) | 2018-02-15 | 2018-02-20 | BORTEZOMIB + THALIDOMIDE | N | null | IPILIMUMAB + NIVOLUMAB | 101429277 |
| 200005826 | 200005826 | null | null | null | null | 2019-10-08 | null | null | null | TRIAL UNSPECIFIED | 101503225 |